CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 322 enrolled
Drug / intervention
Collagenase Clostridium Histolyticum +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02006719
NCT02006719Phase 2Completed
CompareCT.gov

A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder

Endo Pharmaceuticals·interventional·Posted Dec 10, 2013·Updated Oct 5, 2017

In Brief

A Phase 2 clinical trial evaluating Collagenase Clostridium Histolyticum and Placebo for Adhesive Capsulitis and Frozen Shoulder. Completed, enrolled 322 participants across 46 sites in 2 countries.

Detailed Summary

The objectives of this study are to assess the safety, effectiveness, and immunogenicity of AA4500 in the treatment of adhesive capsulitis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdhesive Capsulitis, Frozen Shoulder
CountriesAustralia, United States
Collaborators--

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 10, 2013
Enrollment StartNov 1, 2013
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 12.6 years ago

Interventions

Collagenase Clostridium Histolyticumbiological

Treatment of Adhesive Capsulitis

Placeboother

Placebo injection